BRIEF published on 12/01/2025 at 07:05, 9 months 11 days ago Xlife Sciences AG Unveils NeuroMex for Early Alzheimer’s Detection Healthcare Innovation Xlife Sciences Market Opportunity NeuroMex Alzheimer’s Detection
BRIEF published on 12/01/2025 at 07:05, 9 months 11 days ago Xlife Sciences AG dévoile NeuroMex, un outil pour le dépistage précoce de la maladie d'Alzheimer. Opportunités De Marché Xlife Sciences Détection De La Maladie D'Alzheimer Innovation Dans Le Secteur De La Santé NeuroMex
BRIEF published on 12/01/2025 at 07:05, 9 months 11 days ago Helvetia and Baloise Set Merger Completion for 5 December 2025 Financial Information Merger Baloise SIX Swiss Exchange Helvetia
BRIEF published on 12/01/2025 at 07:05, 9 months 11 days ago Helvetia et Baloise prévoient la finalisation de leur fusion pour le 5 décembre 2025 Baloise SIX Swiss Exchange Informations Financières Fusionnement Helvétie
BRIEF published on 12/01/2025 at 07:05, 9 months 11 days ago Baloise et Helvetia finalisent leur fusion au 5 décembre 2025 Finance Fusion Baloise Cotation Helvetia
BRIEF published on 12/01/2025 at 07:05, 9 months 11 days ago Baloise and Helvetia will finalize their merger on December 5, 2025 Finance Fusion Baloise Helvetia Quoting
BRIEF published on 12/01/2025 at 07:05, 9 months 11 days ago Sandoz Launches Denosumab Biosimilars in Europe Bone Health Sandoz Denosumab Biosimilars Wyost® Jubbonti®
BRIEF published on 12/01/2025 at 07:05, 9 months 11 days ago Sandoz lance des biosimilaires de dénosumab en Europe Sandoz Wyost® Jubbonti® Biosimilaires Du Dénosumab Santé Osseuse
BRIEF published on 12/01/2025 at 07:05, 9 months 11 days ago Recticel Increases Capital Through Subscription Rights Ordinary Shares Recticel Capital Increase Euronext Brussels Subscription Rights
BRIEF published on 12/01/2025 at 07:05, 9 months 11 days ago Recticel augmente son capital grâce à des droits de souscription Recticel Augmentation De Capital Actions Ordinaires Euronext Bruxelles Droits D'abonnement
Published on 09/12/2026 at 02:35, 17 hours 8 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 20 hours 43 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 21 hours 38 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 22 hours 18 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 2 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 hour 52 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 12 hours 12 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 21 hours 28 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 21 hours 32 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 23 hours 58 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 12 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 12 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
